Switzerland’s Covid-19 scientific taskforce chief says hospitals across the Alpine country could be swamped with new coronavirus cases in the next two or three weeks unless the situation improves.
“We estimate that the capacity limit in intensive care in hospitals will be reached between November 5-18 if nothing changes from the current situation,” Martin Ackermann told reporters in Bern on Friday. “We don’t have time to wait any longer.”
The number of new Covid-19 cases has risen sharply in recent days. A total of 6,634 new cases – a record – were reported by the Swiss health authorities on Friday.
They confirmed that the country was now more badly affected than its neighbours: it now has 495 cases per 100,000 inhabitants. Only France approaches these levels at 450 cases per 100,000.
On Friday, Ackermann said that hospitalisations were doubling week by week. The same goes for the number of intensive care cases and deaths due to Covid-19. Over the past 14 days 689 people were hospitalised, and 75 died.
Overall, there have now been more than 100,000 cases – 103,653 cases to be precise – since the start of the epidemic and 1,877 deaths.
Contact to a minimum
He urged people to keep their contact with others to a minimum, while the head of the association of cantonal doctors asked people to avoid “delicate situations”, by keeping to social distancing and avoid risky sports and leisure activities.
Testing and tracing capacity is stretched, with officials appealing to those who test positive to personally inform people with whom they have had contact.
Ackermann told reporters that Switzerland’s containment strategy was no longer working due to the high number of cases. For the virus reproduction rate to drop below 1 again, it is necessary to reduce professional and private contacts by half, he said.
Since the coronavirus pandemic shut down the world, scientists have clamored to develop vaccines to prevent the spread and medicines that will cure the sick. But a virus’ main goal is to replicate and [...]
The highly transmissible delta variant of SARS-CoV-2, the coronavirus causing the disease COVID-19, is now present in 124 countries and will become the dominant strain globally in the coming months as it is outcompeting [...]
Scientists have backed proposals for Covid boosters in the autumn after blood tests on hundreds of people revealed that protective antibodies can wane substantially within weeks of second vaccine shots being given. Falls in [...]
Researchers in the United States have conducted a study showing that the coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna generate a coordinated adaptive immune response that is capable of eliciting recall [...]
CSIRO, Australia's national science agency, played an important role in evaluating heat-tolerant COVID-19 vaccine formulations developed by the Indian Institute of Science (IISc) and biotech start-up Mynvax—against all current SARS-CoV-2 variants of concern. Published [...]
Podcast – Nanovisaging 2040 How Synergies between Nanotechnology, Nanomedicine, and AI might Benefit Humanity
Frank Boehm (NanoApps Medical Inc. Founder) in discussion with Nana Kay in a Wealth Secrets podcast. EP 19. Nanovisaging 2040. From Nana Kay: Nanovisaging 2040: How Synergies between Nanotechnology, Nanomedicine, and AI might Benefit [...]
Canada, like several other countries, has been mixing and matching COVID-19 vaccines for weeks amid safety concerns over the AstraZeneca shot. On Monday, the chief scientist at the World Health Organization (WHO) cautioned against that approach, calling [...]
Scientists have harnessed CRISPR gene-editing technology to block the replication of the novel coronavirus in human cells — an approach that could one day serve as a new treatment for COVID-19. However, the study was performed [...]
A recent study by scientists from Japanese universities has shown that the shape of cell-derived nanoparticles, known as "extracellular vesicles" (EVs), in body fluids could be a biomarker for identifying types of cancer. In [...]
An important lesson for vaccine design Australian scientists researching how our immune system responds to COVID-19 have revealed that those infected by early variants in 2020 produced sustained antibodies, however, these antibodies are not [...]
1. How COVID-19 is affecting the globe Confirmed cases of COVID-19 have passed 185 million globally, according to Johns Hopkins University. The number of confirmed deaths stands at more than 4 million. More than 3.29 [...]
The World Health Organization (WHO) has added another COVID strain to its list of coronavirus variants to keep an eye on: the COVID-19 Lambda variant. This particular variant has now spread to more than two dozen [...]
In a recent study conducted at the Baylor College of Medicine, Houston, USA, scientists have identified six vaccine breakthrough cases caused by the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A [...]
A new Covid-19 strain that is much more dangerous than the Delta variant has been detected in more than 30 countries in the past four weeks, says the Health Ministry. "The Lambda strain was [...]
Weakened lungs and immune systems make people increasingly vulnerable, warn scientists. A rash of cases of a rare “black fungus” infection affecting thousands of critically ill Covid patients in India caused alarm last month. [...]